Persistence and perseverance were the themes of two of our top stories this week.

First there’s the story of Nationwide Children’s Hospital. The Columbus, Ohio, hospital chose to invest in gene therapy when the field was in its darkest days. After some ups and downs, the team it put in place helped advance some of the most promising gene therapies currently in human testing—and put Nationwide in the national spotlight as one of those treatments nears FDA approval.

Then there’s Suzanne Ildstad. A longtime transplant surgeon, Ildstad cobbled together enough money through grant funding to start a company and develop a… Read more »